nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstract index
|
|
|
1998 |
8 |
4 |
p. 353-360 8 p. |
artikel |
2 |
A clinical trial of recombinant human growth hormone treatment of children with myelemingocele
|
Rotenstein, D |
|
1998 |
8 |
4 |
p. 342- 1 p. |
artikel |
3 |
A comparision of three methods of assessing body composition in growth hormone-deficient adults
|
Healy, ML |
|
1998 |
8 |
4 |
p. 345- 1 p. |
artikel |
4 |
A comparison of the growth hormone (GH) response to growth hormone-releasing hormone (GHRH), exercise and placebo in patients with type 2 diabetes mellitus
|
Besser, REJ |
|
1998 |
8 |
4 |
p. 352- 1 p. |
artikel |
5 |
Acute changes of GH levels do not alter leptin serum levels in children and adolescents
|
Bennek, C |
|
1998 |
8 |
4 |
p. 351-352 2 p. |
artikel |
6 |
Adaptation of the growth hormone binding protein LIFA for detection of growth hormone: Growth hormone binding protein complexes
|
Chestnut, RE |
|
1998 |
8 |
4 |
p. 334- 1 p. |
artikel |
7 |
An immunofunctional GH assay: Use in children
|
Mauras, N |
|
1998 |
8 |
4 |
p. 319- 1 p. |
artikel |
8 |
A non-linear model for simulation of growth hormone kinetics
|
Boroujerdi, MA |
|
1998 |
8 |
4 |
p. 334- 1 p. |
artikel |
9 |
A pharmacokinetic and pharmacodynamic study of NNC 26-0703 in Beagle dogs
|
Nielsen, KK |
|
1998 |
8 |
4 |
p. 332- 1 p. |
artikel |
10 |
Association of polymorphism of the GH-1 gene with GH secretion
|
Hasegawa, Y |
|
1998 |
8 |
4 |
p. 329- 1 p. |
artikel |
11 |
Baseline characteristics and diagnosis of GHD in adults with hypopituitarism
|
Feldt-Rasmussen, U |
|
1998 |
8 |
4 |
p. 344- 1 p. |
artikel |
12 |
Baseline leptin and serum GH-binding-protein show a strong correlation in GH-deficient adults
|
Barnard, R |
|
1998 |
8 |
4 |
p. 325- 1 p. |
artikel |
13 |
Beneficial effect of growth hormone (GH) replacement therapy on serum slalic acid levels in adult patients with GH-deficiency
|
Christ, ER |
|
1998 |
8 |
4 |
p. 323- 1 p. |
artikel |
14 |
Biological effects in rats of NNC 26-0703, a new oral growth hormone secretagogue
|
Johansen, PB |
|
1998 |
8 |
4 |
p. 331- 1 p. |
artikel |
15 |
Bone markers and growth hormone (GH) abuse in athletes
|
Wallace, JD |
|
1998 |
8 |
4 |
p. 348- 1 p. |
artikel |
16 |
Changes in body composition, body fat distribution, and energy expenditure in growth hormone deficient children on growth hormone therapy
|
Roemmich, JN |
|
1998 |
8 |
4 |
p. 341-342 2 p. |
artikel |
17 |
Changes in body mass index in girls with turner syndrome
|
Blackett, PR |
|
1998 |
8 |
4 |
p. 343- 1 p. |
artikel |
18 |
Characterization of binding sites involved in the inhibitory action of amylin and calcitonin on GH release in the rat
|
Sibilia, V |
|
1998 |
8 |
4 |
p. 334- 1 p. |
artikel |
19 |
Characterization of GH secretory ability of GH deficient children: Response to MK-0677
|
Yu, H |
|
1998 |
8 |
4 |
p. 332-333 2 p. |
artikel |
20 |
Characterization of rat growth hormone binding protein (GHBP) isoforms
|
Ymer, SI |
|
1998 |
8 |
4 |
p. 336- 1 p. |
artikel |
21 |
Committee
|
|
|
1998 |
8 |
4 |
p. 305- 1 p. |
artikel |
22 |
Comparison between IGF-I and GH in perinatal growth
|
Laron, Z |
|
1998 |
8 |
4 |
p. 319- 1 p. |
artikel |
23 |
Contiguous amino-acid substitutions in the extracellular domain of the growth hormone receptor, identified in patients with laron syndrome, differently affect receptor binding affinity and membrane expression
|
Postel-Vinay, MC |
|
1998 |
8 |
4 |
p. 321- 1 p. |
artikel |
24 |
Continuation of GH treatment for growth hormone deficiency after adolescence
|
Shalet, S |
|
1998 |
8 |
4 |
p. 312- 1 p. |
artikel |
25 |
Detection of growth hormone abuse in athletes
|
Wallace, JD |
|
1998 |
8 |
4 |
p. 329- 1 p. |
artikel |
26 |
Detection of growth hormone abuse in athletes
|
Wallace, JD |
|
1998 |
8 |
4 |
p. 347-348 2 p. |
artikel |
27 |
Determinants of IGF-I in adult turner syndrome: The influence of sex hormones and GH
|
Gravholt, CH |
|
1998 |
8 |
4 |
p. 338- 1 p. |
artikel |
28 |
Determination of free insulin-like growth factor-I in human serum: Comparison of ultra-filtration vs direct immunoradiometric assay
|
Frystyk, J |
|
1998 |
8 |
4 |
p. 337- 1 p. |
artikel |
29 |
Developmental changes in the relationship between IGF-I and body composition during puberty
|
Beckett, Philip R. |
|
1998 |
8 |
4 |
p. 283-288 6 p. |
artikel |
30 |
Diagnosing growth hormone deficiency in adults with hypothalamic-pituitary disease
|
Hoeck, HC |
|
1998 |
8 |
4 |
p. 323- 1 p. |
artikel |
31 |
Diagnosis of adult GH deficiency (GHD): Predictive value of serum IGF-I and number of pituitary hormone deficits
|
Hartman, ML |
|
1998 |
8 |
4 |
p. 344- 1 p. |
artikel |
32 |
Diagnostic discriminatory capacity of three different approaches to the measurement of the acid-labile subunit (ALS)
|
Morrison, KM |
|
1998 |
8 |
4 |
p. 316- 1 p. |
artikel |
33 |
Differential amplification of the pulsatile, nycothemeral and entropic modes of GH secretion by estradiol (E2) or GHRP-2 or both in concert in post-menopausal women
|
Shah, N |
|
1998 |
8 |
4 |
p. 314- 1 p. |
artikel |
34 |
Differential changes in free and total insulin-like growth factor-I after major, elective abdominal surgery: The possible role of insulin-like growth factor binding protein-3 proteolysis
|
Skjaerbaek, C |
|
1998 |
8 |
4 |
p. 338- 1 p. |
artikel |
35 |
Differential effect of growth hormone on cortical and cancellous bone formation in glucocorticoid injected young rats
|
Ortoft, GO |
|
1998 |
8 |
4 |
p. 328- 1 p. |
artikel |
36 |
Differential interactions of insulin-like growth factor binding proteins (1–6) with the ceramide-induced apoptotic signalling pathway in an IGF-independent manner
|
Perks, CM |
|
1998 |
8 |
4 |
p. 339- 1 p. |
artikel |
37 |
Dimensions, densities and mechanical strength of bones from aged growth hormone-transgenic mice
|
Andreassen, TT |
|
1998 |
8 |
4 |
p. 322-323 2 p. |
artikel |
38 |
Discontinuation of GH treatment in adolescent patients: Effects on bone mass
|
Johannsson, Gudmundur |
|
1998 |
8 |
4 |
p. 324- 1 p. |
artikel |
39 |
Discontinuation of GH treatment in adolescent patients: Effects on bone mass
|
Johannsson, Gudmundur |
|
1998 |
8 |
4 |
p. 344- 1 p. |
artikel |
40 |
Discontinuation of GH treatment in adolescent patients: Effects on quality of life and psychological well-being
|
Wirén, Lena |
|
1998 |
8 |
4 |
p. 330- 1 p. |
artikel |
41 |
Discontinuation of GH treatment in adolescent patients: Metabolic effects
|
Johannsson, G |
|
1998 |
8 |
4 |
p. 343-344 2 p. |
artikel |
42 |
Does clinical status correlate with the severity of GH deficiency (GHD) in adults?
|
Colao, A |
|
1998 |
8 |
4 |
p. 316-317 2 p. |
artikel |
43 |
Does growth hormone replacement therapy result in recurrence of increase in the size of pituitary tumours?
|
Hatrick, AG |
|
1998 |
8 |
4 |
p. 318- 1 p. |
artikel |
44 |
Effect of a long-acting growth hormone receptor antagonist on renal enlargement, glomerular hypertrophy and urinary albumin excretion (UAE) in experimental diabetes
|
Flyvbjerg, Allan |
|
1998 |
8 |
4 |
p. 326- 1 p. |
artikel |
45 |
Effect of a sleep debt on the 24-H growth hormone profile in humans
|
L'Hermite-Baleriaux, M |
|
1998 |
8 |
4 |
p. 348- 1 p. |
artikel |
46 |
Effect of GHRH on LH-stimulated progestin in rat ovarian granulosa cells
|
Usuki, Satoshi |
|
1998 |
8 |
4 |
p. 330- 1 p. |
artikel |
47 |
Effect of GH-treatment on bone mineral status in GHD-patients: Gender differences
|
Rosén, T |
|
1998 |
8 |
4 |
p. 349- 1 p. |
artikel |
48 |
Effect of growth hormone deficiency on physical work capacity in patients with non-insulin-dependent diabetes mellitus and excessive body weight
|
Davydov, A |
|
1998 |
8 |
4 |
p. 352- 1 p. |
artikel |
49 |
Effect of short-term IGF-I administration on sperm motility and seminal plasma IGF-I in young healthy males
|
Ovesen, P |
|
1998 |
8 |
4 |
p. 337- 1 p. |
artikel |
50 |
Effect of the GHRP-6 analog hexarelin and arginine alone and combined on GH secretion in patients with active acromegaly
|
Mascadri, C |
|
1998 |
8 |
4 |
p. 331- 1 p. |
artikel |
51 |
Effects of acute IGF-I and IGFBP3 on myocardial contractility: Studies in rat and ferret isolated muscle
|
Cittadini, A |
|
1998 |
8 |
4 |
p. 316- 1 p. |
artikel |
52 |
Effects of fasting, refeeding and systemic growth hormone on the GHRP-6 induction of fos protein in the rat arcuate nucleus
|
Dickson, SL |
|
1998 |
8 |
4 |
p. 313- 1 p. |
artikel |
53 |
Effects of GH and IGF-I in cultured rat ovarian granulosa cells
|
Usuki, S |
|
1998 |
8 |
4 |
p. 336- 1 p. |
artikel |
54 |
Effects of graded treatment with GHRH(1-29)NH2 in older women
|
Hirth, V |
|
1998 |
8 |
4 |
p. 330- 1 p. |
artikel |
55 |
Effects of hGH replacement on cerebral metabolism in adults with growth hormone deficiency
|
Cranston, IC |
|
1998 |
8 |
4 |
p. 317-318 2 p. |
artikel |
56 |
Effects of ipamorelin — A growth hormone secretagogue-on bone formation and skeletal muscle contraction force
|
Andersen, NB |
|
1998 |
8 |
4 |
p. 313- 1 p. |
artikel |
57 |
Effects of 1 year treatment with GH in an old patient with chronic congestive heart failure and GHD
|
Ceda, GP |
|
1998 |
8 |
4 |
p. 350- 1 p. |
artikel |
58 |
Efficacy of, and individual susceptibility to, GH-replacement in adults
|
Monson, JP |
|
1998 |
8 |
4 |
p. 346- 1 p. |
artikel |
59 |
Elderly patients with pituitary insufficiency benefit from growth hormone replacement therapy
|
Thorén, M |
|
1998 |
8 |
4 |
p. 347- 1 p. |
artikel |
60 |
Elevated serum IGF-I is associated with an increased risk of colorectal neoplasia in acromegaly
|
Jenkins, PJ |
|
1998 |
8 |
4 |
p. 351- 1 p. |
artikel |
61 |
Enhancement of growth hormone gene expression in the pituitary and brain by acanthopanax senticosus harms
|
Yoshizato, H |
|
1998 |
8 |
4 |
p. 327- 1 p. |
artikel |
62 |
Evaluation of the outcome of neurosurgical treatment of acromegaly: Relationship between IGF-I and growth hormone at baseline and after oral glucose tolerance test (OGTT) levels
|
Doga, M |
|
1998 |
8 |
4 |
p. 350- 1 p. |
artikel |
63 |
Expression of novel growth hormone receptor (GHR) transcripts in human heart tissue
|
Schwartzbauer, G |
|
1998 |
8 |
4 |
p. 328- 1 p. |
artikel |
64 |
Final height after combined growth hormone and gonadotropin-releasing hormone analog therapy in short healthy children entering into normally time puberty
|
Lanes, R |
|
1998 |
8 |
4 |
p. 342- 1 p. |
artikel |
65 |
Free insulin-like growth factor-I and-II in obesity, niddm and IDDM
|
Orskov, H |
|
1998 |
8 |
4 |
p. 315- 1 p. |
artikel |
66 |
Gender differences in sensitivity to short-term administration of growth hormone (GH) in healthy young adults
|
Edén Engström, B |
|
1998 |
8 |
4 |
p. 347- 1 p. |
artikel |
67 |
Gender-specific dose-responses to GH in GHD children: Results of a 3-year randomized trial in 109 patients
|
Cohen, P |
|
1998 |
8 |
4 |
p. 320- 1 p. |
artikel |
68 |
Genetic defects in the growth hormone/insulin-like growth factors axis
|
Chihara, Kazuo |
|
1998 |
8 |
4 |
p. 312- 1 p. |
artikel |
69 |
Gene transcription of receptors for growth hormone releasing peptides and somatostatin in human pituitary adenomas
|
Nielsen, S |
|
1998 |
8 |
4 |
p. 321- 1 p. |
artikel |
70 |
GHRP-2 + TRH infusion for 5 days during protracted critical illness: Endocrine and metabolic effects
|
Van den Berghe, G |
|
1998 |
8 |
4 |
p. 312- 1 p. |
artikel |
71 |
GH secretion after pharmacological tests (GHRH, clonidine and GHRH+pyridostigmine) both in GH deficient patients and severe obesity
|
Orio Jr, F |
|
1998 |
8 |
4 |
p. 345- 1 p. |
artikel |
72 |
GH secretion in obese children after hypocaloric diet
|
Sgattoni, C |
|
1998 |
8 |
4 |
p. 340- 1 p. |
artikel |
73 |
GH-therapy of a child with short bowel syndrome: A case history about the influence of GH on short-term growth, growth factors and intestinal villi
|
Keller, A |
|
1998 |
8 |
4 |
p. 342-343 2 p. |
artikel |
74 |
GH treatment of childhood-onset adult GH deficiency: Results of a 2-year placebocontrolled trial
|
Underwood, LE |
|
1998 |
8 |
4 |
p. 317- 1 p. |
artikel |
75 |
Growth hormone administration conserves nitrogen and accelerates lipolysis during dietary restriction in obese subjects
|
Noorrelund, H |
|
1998 |
8 |
4 |
p. 323-324 2 p. |
artikel |
76 |
Growth hormone and cognitive function in healthy older men
|
Aleman, A |
|
1998 |
8 |
4 |
p. 329- 1 p. |
artikel |
77 |
Growth hormone and faconi anemia
|
Doerr, HG |
|
1998 |
8 |
4 |
p. 343- 1 p. |
artikel |
78 |
Growth hormone axis-independent growth
|
Hathout, EH |
|
1998 |
8 |
4 |
p. 340- 1 p. |
artikel |
79 |
Growth hormone decreases hepatic amino acid degradation after major surgery in rats
|
Ljungmann, K |
|
1998 |
8 |
4 |
p. 335- 1 p. |
artikel |
80 |
Growth hormone enhances expression and DNA binding activity of CCAAT/enhancer binding protein-β (C/EBPα) in primary cultures of rat hepatocytes
|
Jansson, J-O |
|
1998 |
8 |
4 |
p. 321- 1 p. |
artikel |
81 |
Growth hormone (GH) rebound response after somatostatin (SRIH) withdrawal is blunted in human obesity
|
Ambrosio, MR |
|
1998 |
8 |
4 |
p. 331- 1 p. |
artikel |
82 |
Growth hormone (GH) status following cure of cushing's disease
|
Hughes, NR |
|
1998 |
8 |
4 |
p. 317- 1 p. |
artikel |
83 |
Growth hormone increases VLDL apolipoprotein B100 secretion and clearance rate
|
Christ, ER |
|
1998 |
8 |
4 |
p. 326- 1 p. |
artikel |
84 |
Growth hormone induces a substantial turnover of lung collagens in old rats
|
Oxlund, H. |
|
1998 |
8 |
4 |
p. 335- 1 p. |
artikel |
85 |
Growth hormone receptor-dependent expression of IGFBP-4 mRNA in chicken liver
|
Tanaka, M |
|
1998 |
8 |
4 |
p. 338-339 2 p. |
artikel |
86 |
Growth hormone replacement in adults with GH deficiency—the first 10 years
|
Sonksen, Peter H |
|
1998 |
8 |
4 |
p. 275-276 2 p. |
artikel |
87 |
Growth hormone replacement therapy increases handgrip strength in 21 growth hormone-deficient adults
|
Tschöp, M |
|
1998 |
8 |
4 |
p. 348- 1 p. |
artikel |
88 |
Growth hormone resistant states: Pathophysiology and treatment
|
Underwood, Louis |
|
1998 |
8 |
4 |
p. 311-312 2 p. |
artikel |
89 |
Growth hormone secretagogue ipamorelin reduces the hepatic catabolic stress response during steroid treatment
|
Grofte, T |
|
1998 |
8 |
4 |
p. 312-313 2 p. |
artikel |
90 |
Growth hormone signal transduction
|
Carter-Su, Christin |
|
1998 |
8 |
4 |
p. 311- 1 p. |
artikel |
91 |
Heart structure and function in dwarf rats in vivo before and after GH replacement: Echocardiographic evaluation
|
Cittadini, A |
|
1998 |
8 |
4 |
p. 328- 1 p. |
artikel |
92 |
Hemostatic variables in patients with GH excess or deficiency
|
Sartorio, A |
|
1998 |
8 |
4 |
p. 350- 1 p. |
artikel |
93 |
Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells
|
Jansson, J-O |
|
1998 |
8 |
4 |
p. 315-316 2 p. |
artikel |
94 |
Hexarelin improves heart function in rats after experimental myocardial infarction without an increase in cardiac IGF-I mRNA
|
Tivesten, A |
|
1998 |
8 |
4 |
p. 331- 1 p. |
artikel |
95 |
Human thymic cells produce GH and express GH receptors
|
Postel-Vinay, MC |
|
1998 |
8 |
4 |
p. 334- 1 p. |
artikel |
96 |
Identification of a serum factor that binds and alters the GH binding properties of rat GH-binding protein
|
Leung, KC |
|
1998 |
8 |
4 |
p. 327-328 2 p. |
artikel |
97 |
IGF-I but not an IGF-I analog increases serum IGF binding protein-3 (IGFBP-3) in adolescent female monkeys
|
Wilson, ME |
|
1998 |
8 |
4 |
p. 315- 1 p. |
artikel |
98 |
IGF-I expression is downregulated in hypertrophic growth-plate chondrocytes in vivo but not in vitro
|
Olney, RC |
|
1998 |
8 |
4 |
p. 336-337 2 p. |
artikel |
99 |
IGF-I generation test: Effects on body composition
|
Longobardi, S |
|
1998 |
8 |
4 |
p. 340- 1 p. |
artikel |
100 |
IGF-I response to short-term administration of low RHGH dose as function of sex, age and pathophysiological conditions
|
Arvat, E |
|
1998 |
8 |
4 |
p. 337-338 2 p. |
artikel |
101 |
IGF-I variability during GHRH treatment: Effect of diet control
|
Merriam, GR |
|
1998 |
8 |
4 |
p. 330- 1 p. |
artikel |
102 |
Increased disorderliness and decreased mass and daily rate of endogenous growth hormone secretion in adult turner syndrome: the impact of body composition, maximal oxygen uptake and treatment with sex hormones
|
Gravholt, Claus Højbjerg |
|
1998 |
8 |
4 |
p. 289-298 10 p. |
artikel |
103 |
Increased gene expression of a truncated growth hormone (GH) receptor relative to the full-length receptor after 4 months of GH substitution in GH deficient adults
|
Fisker, S |
|
1998 |
8 |
4 |
p. 323- 1 p. |
artikel |
104 |
Insulin-like growth factor binding protein-4 accumulation is negatively correlated with growth rate in TM-3 cells
|
Hasegawa, Tomonobu |
|
1998 |
8 |
4 |
p. 277-282 6 p. |
artikel |
105 |
Insulin-like growth factor binding protein-2 (IGFBP-2) levels are elevated in patients with acromegaly and colonic neoplasia
|
Miraki-Moud, F |
|
1998 |
8 |
4 |
p. 351- 1 p. |
artikel |
106 |
Insulin like growth factor I (IGF-1) administration induces fluid and sodium retention in healthy adults
|
Mooller, J |
|
1998 |
8 |
4 |
p. 324-325 2 p. |
artikel |
107 |
Insulin-like growth factor-1 stimulates vascular smooth muscle cell proliferation in rat aorta in vivo
|
Chen, Y. |
|
1998 |
8 |
4 |
p. 299-303 5 p. |
artikel |
108 |
Insulin requirements decrease after 2 weeks of subcutaneous administration of B2036-PEG (Trovert-tm), a growth hormone antagonist, to type I diabetics
|
Schwartz, SL |
|
1998 |
8 |
4 |
p. 352- 1 p. |
artikel |
109 |
Involvement of mitogen-activated protein kinase (MAPK and the insulin-like growth factor-i receptor (IGF-IR) in apoptosis
|
Stewart, CEH |
|
1998 |
8 |
4 |
p. 333- 1 p. |
artikel |
110 |
Ipamorelin — A novel very potent growth hormone secretagogue
|
Rasmussen, MH |
|
1998 |
8 |
4 |
p. 332- 1 p. |
artikel |
111 |
20K GH isoforms in small for gestational age infants
|
Chasalow, FI |
|
1998 |
8 |
4 |
p. 341- 1 p. |
artikel |
112 |
20-Kilodalton(KDA) human growth hormone in human pituitaries and GH-secreting pituitary adenomas
|
Sanno, N |
|
1998 |
8 |
4 |
p. 336- 1 p. |
artikel |
113 |
L-agrinine-induced growth hormone secretion is not influenced by co-infusion of the no synthase inhibitior N-monomethyl-L-arginine in healthy men
|
Fisker, S |
|
1998 |
8 |
4 |
p. 345- 1 p. |
artikel |
114 |
Leptin levels and GH dynamics in obesity: Variations after biliopancreatic diversion
|
De Marinis, L |
|
1998 |
8 |
4 |
p. 325-326 2 p. |
artikel |
115 |
Leptin levels in protracted critical illness: Effects of GH-secretagogues and TRH
|
Van den Berghe, G |
|
1998 |
8 |
4 |
p. 326- 1 p. |
artikel |
116 |
Lipolysis stimulation by 20 K hGH in 3T3-L1-hGHR
|
Asada, N |
|
1998 |
8 |
4 |
p. 336- 1 p. |
artikel |
117 |
Longitudinal changes in growth hormone release, body composition, and body fat distribution are inversely related in children and adolescents
|
Roemmich, JN |
|
1998 |
8 |
4 |
p. 319- 1 p. |
artikel |
118 |
Long-term safeety during growth hormone (GH) treatment of GH-deficient adults: A one-center study
|
Bengtsson, B-A |
|
1998 |
8 |
4 |
p. 318- 1 p. |
artikel |
119 |
Long-term safety during growth hormone (GH) treatment of GH-deficient adults: A one-center study
|
Bengtsson, B-A |
|
1998 |
8 |
4 |
p. 347- 1 p. |
artikel |
120 |
Measurement of serum 20K-hGH in children
|
Ishikawa, M |
|
1998 |
8 |
4 |
p. 319- 1 p. |
artikel |
121 |
Methylprednisolone does not inhibit the release of growth hormone after intravenous injection of a novel growth hormone secretagogue in rats
|
Malmlof, K |
|
1998 |
8 |
4 |
p. 332- 1 p. |
artikel |
122 |
Monitoring response to growth hormone replacement-an ideal model
|
Simpson, HL |
|
1998 |
8 |
4 |
p. 346- 1 p. |
artikel |
123 |
New developments in the neuroendocrine control of GH: Lessons from GH secretagogues
|
Bach, MA |
|
1998 |
8 |
4 |
p. 311- 1 p. |
artikel |
124 |
NNC 26-0703, an orally active specific growth hormone secretagogue
|
Raun, K |
|
1998 |
8 |
4 |
p. 314- 1 p. |
artikel |
125 |
No acute effect of insulin on insulin-like growth factor binding protein 3 (IGFBP-3) proteolysis in healthy subjects
|
Flyvbjerg, A |
|
1998 |
8 |
4 |
p. 338- 1 p. |
artikel |
126 |
Nuclear translocation of transcription factor MSY-1 plays a role in pregnancy-specific expression of the GH receptor (GHR) gene
|
Menon, RK |
|
1998 |
8 |
4 |
p. 322- 1 p. |
artikel |
127 |
Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults
|
Drake, WM |
|
1998 |
8 |
4 |
p. 346- 1 p. |
artikel |
128 |
Pharmacokinetics of ipamorelin, a new GH secretagogue, after iontophoretic and intravenous administration to volunteers
|
Green, P |
|
1998 |
8 |
4 |
p. 332- 1 p. |
artikel |
129 |
Pituitary cell transplantation in dwarf rats
|
Robinson, ICAF |
|
1998 |
8 |
4 |
p. 327- 1 p. |
artikel |
130 |
Plasma disappearance rate of free insulinlike growth factor-I in healthy subjects
|
Frystyk, J |
|
1998 |
8 |
4 |
p. 314-315 2 p. |
artikel |
131 |
Progesterone modulates the effects of estrogen on IGFI in post-menopausal women
|
Ho, KKY |
|
1998 |
8 |
4 |
p. 316- 1 p. |
artikel |
132 |
Program for the 1998 Growth Hormone Research Society Conference
|
|
|
1998 |
8 |
4 |
p. 306-307 2 p. |
artikel |
133 |
Randomized, double-blind, placebo-controlled trial of growth hormone in patients with dilated cardiomyopathy
|
Osterziel, KJ |
|
1998 |
8 |
4 |
p. 349- 1 p. |
artikel |
134 |
Recombinant growth hormone has an anabolic effect on bone formation in distraction osteogenesis
|
Raschke, M |
|
1998 |
8 |
4 |
p. 335-336 2 p. |
artikel |
135 |
Reduced retinal vascularization in children with growth hormone insufficiency
|
Hellström, A |
|
1998 |
8 |
4 |
p. 341- 1 p. |
artikel |
136 |
Regrowth of non-secreting pituitary adenoma and craniopharyngioma prior to GH-replacement therapy in KIMS
|
Wilton, P |
|
1998 |
8 |
4 |
p. 318- 1 p. |
artikel |
137 |
Regulation of the GH/IGF axis in the denning black bear (Ursus Americanus)
|
Unterman, TG |
|
1998 |
8 |
4 |
p. 329- 1 p. |
artikel |
138 |
Resting metabolic rate in healthy adults: Relation to growth hormone status and leptin levels
|
Dall, R |
|
1998 |
8 |
4 |
p. 351- 1 p. |
artikel |
139 |
Revascularization and/or partially-maintained hypothalamic-pituitary portal system in patients with pituitary stalk transection
|
Momoi, T |
|
1998 |
8 |
4 |
p. 341- 1 p. |
artikel |
140 |
RHIGF-I administration increases in vivo peripheral insulin sensitivity in adults with type 1 diabetes mellitus
|
Carroll, PV |
|
1998 |
8 |
4 |
p. 315- 1 p. |
artikel |
141 |
Secular trend in Israeli population and its effect on the ICP growth model of Karlberg (20 years of cross-sectional and longitudinal data)
|
Zadik, Zvi |
|
1998 |
8 |
4 |
p. 340- 1 p. |
artikel |
142 |
Serum acid-labile subunit levels in 31 patients with non-islet cell tumor hypoglycemia
|
Hizuka, N |
|
1998 |
8 |
4 |
p. 339- 1 p. |
artikel |
143 |
Serum free insulin-like growth factor-I decreases during the night in healthy subjects and acromegalic patients but not in growth-hormone-deficient patients
|
Skj˦rbr˦k, C |
|
1998 |
8 |
4 |
p. 337- 1 p. |
artikel |
144 |
Serum levels of the acid-labile subunit of the 150 KDA insulin-like growth factor binding protein complex: Impact of mode of growth hormone administration
|
Laursen, T |
|
1998 |
8 |
4 |
p. 339- 1 p. |
artikel |
145 |
Severe growth hormone (GH) deficiency: One test VS two tests — The evidence
|
Lissett, CA |
|
1998 |
8 |
4 |
p. 344-345 2 p. |
artikel |
146 |
Short-term effects of growth hormone on bone metabolism in a patient with mild hunter disease
|
Desenzani, P |
|
1998 |
8 |
4 |
p. 343- 1 p. |
artikel |
147 |
Somatostatin analogs selective for sub-type 2 and 5 of the somatostatin receptor suppress with different patterns growth hormone (GH) secretion in human GH-secreting adenomas cultured in vitro
|
Giustina, A |
|
1998 |
8 |
4 |
p. 314- 1 p. |
artikel |
148 |
STAT 5 messenger RNA in normal and malnourished rats is upregulated by growth hormone treatment
|
Ortiz, BL |
|
1998 |
8 |
4 |
p. 322- 1 p. |
artikel |
149 |
Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and non-peptide secretagogues
|
Howard, AD |
|
1998 |
8 |
4 |
p. 313-314 2 p. |
artikel |
150 |
Sustained-release growth hormone in children and adults
|
Kemp, SF |
|
1998 |
8 |
4 |
p. 320-321 2 p. |
artikel |
151 |
Systemic application of recombinant growth hormone increases the callus area in distraction osteogenesis
|
Kolbeck, S |
|
1998 |
8 |
4 |
p. 335- 1 p. |
artikel |
152 |
The acid-labile subunit (ALS) of the 150 K complex in critically ill patients
|
Barreca, A |
|
1998 |
8 |
4 |
p. 339-340 2 p. |
artikel |
153 |
The anabolic effect of recombinant growth hormoe (GH) on osteoblasts in distraction osteogenesis may be IGF-I mediated
|
Bail, H |
|
1998 |
8 |
4 |
p. 333-334 2 p. |
artikel |
154 |
The effect of a physiological growth hormone pulse on lipolysis in abdominal and femoral adipose tissue assessed by microdialysis
|
Gravholt, CH |
|
1998 |
8 |
4 |
p. 325- 1 p. |
artikel |
155 |
The effect of growth hormone treatment in idiopathic short stature with shox mutation
|
Vaguin, P |
|
1998 |
8 |
4 |
p. 320- 1 p. |
artikel |
156 |
The effect of long-term growth hormone administration on the collagen concentration, relative amounts of type I and III collagen and pyridinoline collagen cross-links in rat hearts
|
Bruel, A |
|
1998 |
8 |
4 |
p. 328- 1 p. |
artikel |
157 |
The effects of glutamine supplementation, GH and IGF-I on glutamine metabolism in the critically ILL
|
Jackson, N |
|
1998 |
8 |
4 |
p. 324- 1 p. |
artikel |
158 |
The effects of 10 years of recombinant human growth hormone
|
Healy, ML |
|
1998 |
8 |
4 |
p. 349- 1 p. |
artikel |
159 |
The effects of 10 years of recombinant human growth hormone
|
Gibney, J |
|
1998 |
8 |
4 |
p. 349- 1 p. |
artikel |
160 |
The GH-receptor associates with Jak1, Jak2 and Tyk2 in human liver
|
Hellgren, G |
|
1998 |
8 |
4 |
p. 321-322 2 p. |
artikel |
161 |
The growth-hormone IGF-I axis in patients with chronic heart failure and cachexia: GH resistance and lack of glucose-suppressibility of GH levels
|
Pflaum, CD |
|
1998 |
8 |
4 |
p. 326-327 2 p. |
artikel |
162 |
The growth hormone response to exercise and its relationship to menstrual cycle stage
|
Hills, N |
|
1998 |
8 |
4 |
p. 348-349 2 p. |
artikel |
163 |
The increase in muscle strength during rhgh therapy is due to an increase in muscle mass
|
Janssen, YJH |
|
1998 |
8 |
4 |
p. 318- 1 p. |
artikel |
164 |
The insulin antagonistic effect of GH does not affect myocardial glucose uptake in healthy human subjects
|
Botker, HE |
|
1998 |
8 |
4 |
p. 327- 1 p. |
artikel |
165 |
The metacarpal index in short stature before and during growth hormone therapy
|
Bettendorf, M |
|
1998 |
8 |
4 |
p. 342- 1 p. |
artikel |
166 |
The modulation of cortisol metabolism by low-dose GH replacement in elderly hypopituitary patients
|
Toogood, AA |
|
1998 |
8 |
4 |
p. 324- 1 p. |
artikel |
167 |
The role of GH/IGF-I/cAMP/protein kinase a axis in the control of apoptosis and secretory activity of bovine ovarian granulosa cells
|
Sirotkin, A |
|
1998 |
8 |
4 |
p. 333- 1 p. |
artikel |
168 |
The role of growth hormone (GH) and glucocorticoid (GC) in glucose intolerance and insulin resistance in vivo
|
Johansen, T |
|
1998 |
8 |
4 |
p. 352- 1 p. |
artikel |
169 |
The role of suppressors of cytokine signaling (SOCS) in growth hormone (GH) receptor signaling
|
Billestrup, N |
|
1998 |
8 |
4 |
p. 322- 1 p. |
artikel |
170 |
Thyroid and growth hormone (GH)/insulin-like growth factor-I (IGF-I) axis: A clinical and utrasonographic study in patients with acromegaly and hypopituitarism
|
Colao, A |
|
1998 |
8 |
4 |
p. 350- 1 p. |
artikel |
171 |
Treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 does not increase lipoprotein(A) concentrations
|
Svensson, J |
|
1998 |
8 |
4 |
p. 333- 1 p. |
artikel |
172 |
Treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: 2-year results
|
Hochhaus, F |
|
1998 |
8 |
4 |
p. 320- 1 p. |
artikel |
173 |
10 years of experience in the growth hormone treatment of adult GH deficiency
|
Russell-Jones, DL |
|
1998 |
8 |
4 |
p. 311- 1 p. |
artikel |